After hearing about quality control lapses at a Moderna COVID-19 vaccine manufacturing facility, ICAN’s legal team immediately sent FOIA requests to FDA for more details. ICAN has now obtained FDA’s inspection report, which includes detailed descriptions about the conditions at the plant. In addition, ICAN submitted follow-up requests to dig […]